
Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial
March 06, 2025 2 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: The difference in 90 …